ABSTRACT
Individuals with methamphetamine use disorder (MUD) often experience anxiety and depressive symptoms during abstinence, which can worsen the likelihood of relapse. Thus, it is essential to understand the neuro-mechanism behind methamphetamine use and its associated emotional withdrawal symptoms in order to develop effective clinical strategies. This study aimed to evaluate associations between emotional withdrawal symptoms and structural covariance networks (SCNs) based on cortical thickness (CTh) across the brain. The CTh measures were obtained from Tl-weighted MRI data from a sample of 48 males with MUD during abstinence and 48 male healthy controls. The severity of anxiety and depressive symptoms was assessed by the Hamilton Anxiety Scale (HAMA) and depression (HAMD) scales. Two important nodes belonging to the brain reward system, the right rostral anterior cingulate cortex (rACC) and medial prefrontal cortex (medPFC), were selected as seeds to conduct SCNs and modulation analysis by emotional symptoms. MUDs showed higher structural covariance between the right rACC and regions in the dorsal attention, right frontoparietal, auditory, visual and limbic networks. They also displayed higher structural covariance between the right medPFC and regions in the limbic network. Moreover, the modulation analysis showed that higher scores on HAMA were associated with increased covariance between the right rACC and the left parahippocampal and isthmus cingulate cortex in the default mode network. These outcomes shed light on the complex neurobiological mechanisms underlying methamphetamine use and its associated emotional withdrawal symptoms and may provide new insights into the development of effective treatments for MUD.
Subject(s)
Emotions , Substance Withdrawal Syndrome , Humans , Male , Brain/diagnostic imaging , Anxiety/diagnostic imaging , Magnetic Resonance Imaging , Brain Mapping , Substance Withdrawal Syndrome/diagnostic imagingABSTRACT
Higher sensitivity to reward (SR) and weaker sensitivity to punishment (SP) construct the fundamental craving characteristics of methamphetamine abuse. However, few studies have appraised relationships between SR/SP (SR or SP) and cortical morphological alterations in methamphetamine abusers and whether hereditary factors take effects on SR/SP is unclear. Based on surface-based morphometric analysis, cortical discrepancy was investigated between 38 methamphetamine abusers and 37 healthy controls. Within methamphetamine abusers, correlation profiling was performed to discover associations among aberrant neuroimaging substrates, SR, SP, and craving. According to nine single nucleotide polymorphism sites of dopamine-related genes, we conducted univariate general linear model to find different effects of genotypes on cortical alterations and SR/SP/craving (SR, SP, or craving). Ultimately, mediation analyses were conducted among single nucleotide polymorphism sites, SR/SP/craving, and cortical morphological alterations to discover their association pathways. Compared to healthy controls, thinner cortices in inferior temporal gyrus, lateral orbitofrontal cortex, medial orbitofrontal cortex, inferior parietal lobule, and lateral occipital cortex in the left hemisphere were found in methamphetamine abusers (P < 0.05, family-wise error corrected). Cortical thickness in the inferior temporal gyrus was negatively correlated with SR scores. We found that rs1800497 A-containing genotypes had lower cortical thickness in the left inferior parietal lobule than the GG genotype. The rs5751876 had effects on SR scores. This study would provide convincing biomarkers for SR in methamphetamine abusers and offer potential genetic targets for personalizing relapse prevention.
Subject(s)
Amphetamine-Related Disorders , Cerebral Cortex , Magnetic Resonance Imaging , Methamphetamine , Polymorphism, Single Nucleotide , Reward , Humans , Male , Adult , Amphetamine-Related Disorders/genetics , Amphetamine-Related Disorders/diagnostic imaging , Amphetamine-Related Disorders/pathology , Methamphetamine/adverse effects , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Female , Young Adult , Substance Withdrawal Syndrome/genetics , Substance Withdrawal Syndrome/pathology , Substance Withdrawal Syndrome/psychology , Substance Withdrawal Syndrome/diagnostic imaging , Craving/physiology , PunishmentABSTRACT
This study evaluates the long-term effects of a six and 14-week morphine withdrawal in rats pretreated with a cannabinoid agonist (CP-55,940, CP) during periadolescence. Wistar rats (33 males; 32 females) were treated with CP or its vehicle (VH) from postnatal day (PND) 28-38. At PND100, rats performed morphine self-administration (MSA, 15d/12 h/session). Eight groups were defined according to pretreatment (CP), treatment (morphine), and sex. Three [18F]FDG-PET brain images were acquired: after MSA, and after six and 14 weeks of withdrawal. PET data were analyzed with SPM12. Endocannabinoid (EC) markers were evaluated in frozen brain tissue at endpoint. Females showed a higher mean number of self-injections than males. A main Sex effect on global brain metabolism was found. FDG uptake in males was discrete, whereas females showed greater brain metabolism changes mainly in areas of the limbic system after morphine treatment. Moreover, the morphine-induced metabolic pattern in females was exacerbated when CP was previously present. In addition, the CP-Saline male group showed reduced CB1R, MAGL expression, and NAPE/FAAH ratio compared to the control group, and morphine was able to reverse CB1R and MAGL expression almost to control levels. In conclusion, females showed greater and longer-lasting metabolic changes after morphine withdrawal than males, indicating a higher vulnerability and a different sensitivity to morphine in subjects pre-exposed to CP. In contrast, males primarily showed changes in EC markers. Together, our results suggest that CP pre-exposure contributes to the modulation of brain metabolism and EC systems in a sex-dependent manner.
Subject(s)
Morphine , Substance Withdrawal Syndrome , Female , Rats , Animals , Male , Morphine/pharmacology , Cannabinoid Receptor Agonists/pharmacology , Rats, Wistar , Fluorodeoxyglucose F18 , Endocannabinoids , Neuroimaging , Glucose , Substance Withdrawal Syndrome/diagnostic imagingABSTRACT
INTRODUCTION: Cerebral Venous Sinus Thrombosis (CVST) remains a challenge to diagnose due to its rarity and nonspecific symptomatology. We have found alcohol withdrawal can display symptoms similar to CVST. We present a unique case of intraparenchymal hemorrhage secondary to an extensive CVST in a patient presenting with symptoms suggestive of alcohol withdrawal. CASE REPORT: A 33-year-old woman with a history of alcohol dependence presented with a worsening headache and right upper dental pain. She denied any trauma and attributed the headache to alcohol withdrawal. She denied consuming alcohol in the last 24 hours but reported a daily intake of 20 oz of whiskey. Physical examination noted dental caries and a normal neurological examination. Laboratory values indicated leukocytosis with neutrophilia and microcytic anemia. Computed tomography brain without contrast was conducted to rule out head trauma, revealing a 1.2 cm intraparenchymal hemorrhage in the left frontal lobe with local edema. Neurosurgery recommended a computed tomography angiography, which demonstrated contrast filling defects consistent with CVST (confirmed by magnetic resonance venography). The patient was admitted to the intensive care unit; during her hospital course, further testing revealed heterozygous methylenetetrahydrofolate reductase mutation and elevated homocysteine levels. Patient underwent acute treatment with enoxaparin bridged to apixaban. Patient was discharged on day 7 neurologically intact with the improvement of all symptoms. CONCLUSION: This unique presentation of CVST alongside alcohol withdrawal symptoms highlights the importance of recognizing atypical presentations of CVST in higher-risk patient populations. A heightened index of suspicion for the wide range of presentations of CVST is necessary to assess, diagnose, and treat at-risk patients.
Subject(s)
Alcoholism , Dental Caries , Sinus Thrombosis, Intracranial , Substance Withdrawal Syndrome , Female , Humans , Adult , Alcoholism/complications , Sinus Thrombosis, Intracranial/complications , Sinus Thrombosis, Intracranial/diagnostic imaging , Dental Caries/complications , Substance Withdrawal Syndrome/complications , Substance Withdrawal Syndrome/diagnostic imaging , Headache/complicationsABSTRACT
Chronic alcohol use increases risk of alcohol withdrawal symptoms (AW) and disrupts stress biology and resilient coping, thereby promoting excessive alcohol intake. Chronic alcohol intake and multiple alcohol detoxifications are known to impair brain medial prefrontal cortex (mPFC) and striatal functioning, regions involved in regulating stress, craving and alcohol intake. In two related studies, we examined whether AW predicts this functional brain pathology and whether Prazosin versus Placebo treatment may reverse these effects. In Study 1, patients with Alcohol Use Disorder (AUD) (N = 45) with varying AW levels at treatment entry were assessed to examine AW effects on corticostriatal responses to stress, alcohol cue and neutral visual images with functional magnetic resonance imaging (fMRI). In Study 2, 23 AUD patients entering a 12-week randomised controlled trial (RCT) of Prazosin, an alpha1 adrenergic antagonist that decreased withdrawal-related alcohol intake in laboratory animals, participated in two fMRI sessions at pretreatment and also at week 9-10 of chronic treatment (Placebo: N = 13; Prazosin: N = 10) to assess Prazosin treatment effects on alcohol-related cortico-striatal dysfunction. Study 1 results indicated that higher AW predicted greater disruption in brain mPFC and striatal response to stress and alcohol cues (p < 0.001, family-wise error [FWE] correction) and also subsequently greater heavy drinking days (HDD) in early treatment (p < 0.01). In Study 2, Prazosin versus Placebo treatment reversed mPFC-striatal dysfunction (p < 0.001, FWE), which in turn predicted fewer drinking days (p < 0.01) during the 12-week treatment period. These results indicate that AW is a significant predictor of alcohol-related prefrontal-striatal dysfunction, and Prazosin treatment reversed these effects that in turn contributed to improved alcohol treatment outcomes.
Subject(s)
Alcoholism , Substance Withdrawal Syndrome , Alcohol Drinking , Alcoholism/diagnostic imaging , Alcoholism/drug therapy , Craving/physiology , Humans , Prazosin/pharmacology , Prazosin/therapeutic use , Substance Withdrawal Syndrome/diagnostic imaging , Substance Withdrawal Syndrome/drug therapyABSTRACT
Numerous brain regions have been identified as contributing to withdrawal behaviors, but it is unclear the way in which these brain regions as a whole lead to withdrawal. The search for a final common brain pathway that is involved in withdrawal remains elusive. To address this question, we implanted osmotic minipumps containing either saline, nicotine (24 mg/kg/d), cocaine (60 mg/kg/d), or methamphetamine (4 mg/kg/d) for one week in male C57BL/6J mice. After one week, the minipumps were removed and brains collected 8 h (saline, nicotine, and cocaine) or 12 h (methamphetamine) after removal. We then performed single-cell whole-brain imaging of neural activity during the withdrawal period when brains were collected. We used hierarchical clustering and graph theory to identify similarities and differences in brain functional architecture. Although methamphetamine and cocaine shared some network similarities, the main common neuroadaptation between these psychostimulant drugs was a dramatic decrease in modularity, with a shift from a cortical-driven to subcortical-driven network, including a decrease in total hub brain regions. These results demonstrate that psychostimulant withdrawal produces the drug-dependent remodeling of functional architecture of the brain and suggest that the decreased modularity of brain functional networks and not a specific set of brain regions may represent the final common pathway associated with withdrawal.
Subject(s)
Cocaine , Substance Withdrawal Syndrome , Animals , Brain/diagnostic imaging , Male , Mice , Mice, Inbred C57BL , Neuroimaging , Substance Withdrawal Syndrome/diagnostic imagingABSTRACT
Currently available therapies for smoking cessation have limited efficacy, and potential treatments that target specific brain regions are under evaluation, with a focus on the insula. The ventral and dorsal anterior subregions of the insula serve distinct functional networks, yet our understanding of how these subregions contribute to smoking behavior is unclear. Resting-state functional connectivity (RSFC) provides a window into network-level function associated with smoking-related internal states. The goal of this study was to determine potentially distinct relationships of ventral and dorsal anterior insula RSFC with cigarette withdrawal after brief abstinence from smoking. Forty-seven participants (24 women; 18-45 years old), who smoked cigarettes daily and were abstinent from smoking overnight (~12 h), provided self-reports of withdrawal and underwent resting-state fMRI before and after smoking the first cigarette of the day. Correlations between withdrawal and RSFC were computed separately for ventral and dorsal anterior insula seed regions in whole-brain voxel-wise analyses. Withdrawal was positively correlated with RSFC of the right ventral anterior insula and dorsal anterior cingulate cortex (dACC) before but not after smoking. The correlation was mainly due to a composite effect of craving and physical symptoms of withdrawal. These results suggest a role of right ventral anterior insula-dACC connectivity in the internal states that maintain smoking behavior (e.g., withdrawal) and present a specific neural target for brain-based therapies seeking to attenuate withdrawal symptoms in the critical early stages of smoking cessation.
Subject(s)
Cigarette Smoking , Smoking Cessation , Substance Withdrawal Syndrome , Adolescent , Adult , Brain Mapping , Cerebral Cortex/diagnostic imaging , Cigarette Smoking/adverse effects , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Smoking , Substance Withdrawal Syndrome/diagnostic imaging , Young AdultABSTRACT
Anxiety and depression are the most common withdrawal symptoms of methamphetamine (METH) abuse, which further exacerbate relapse of METH abuse. To date, no effective pharmacotherapy exists for METH abuse and its withdrawal symptoms. Therefore, understanding the neuromechanism underlying METH abuse and its withdrawal symptoms is essential for developing clinical strategies and improving patient care. The aims of this study were to investigate brain network abnormalities in METH abusers (MAs) and their associations with affective symptoms. Forty-eight male abstinent MAs and 48 age-gender matched healthy controls were recruited and underwent resting state functional magnetic resonance imaging (fMRI). The severity of patient anxiety and depressive symptoms were measured by Hamilton anxiety and depression rating scales, which decreased across the duration of abstinence. Independent component analysis was used to investigate the brain network functional connectivity (FC) properties. Compared with healthy controls, MAs demonstrated hypo-intra-network FC in the cerebellar network and hyper-intra-network FC in the posterior salience network. A whole-brain regression analysis revealed that FC strength of clusters located in the right rostral anterior cingulate cortex (rACC) within the ventromedial network (VMN) was associated with affective symptoms in the patients. Importantly, the intra-network FC strength of the rACC in VMN mediated the association between abstinence duration and the severity level of affective symptoms. Our results demonstrate alterations in brain functional networks underlying METH abuse, and that the FC of rACC within VMN serve as a neural substrate in the association between abstinence length and affective symptom severity in the MAs.
Subject(s)
Amphetamine-Related Disorders/physiopathology , Anxiety/physiopathology , Central Nervous System Stimulants/adverse effects , Cerebral Cortex/physiopathology , Connectome , Depression/physiopathology , Methamphetamine/adverse effects , Nerve Net/physiopathology , Substance Withdrawal Syndrome/physiopathology , White Matter/physiopathology , Adult , Amphetamine-Related Disorders/complications , Amphetamine-Related Disorders/diagnostic imaging , Anxiety/diagnostic imaging , Anxiety/etiology , Cerebral Cortex/diagnostic imaging , Depression/diagnostic imaging , Depression/etiology , Humans , Magnetic Resonance Imaging , Male , Nerve Net/diagnostic imaging , Substance Withdrawal Syndrome/complications , Substance Withdrawal Syndrome/diagnostic imaging , White Matter/diagnostic imaging , Young AdultABSTRACT
Methamphetamine (MA) could induce functional and structural brain alterations in dependent subjects. However, few studies have investigated resting-state activity in methamphetamine-dependent subjects (MADs). We aimed to investigate alterations of brain activity during resting-state in MADs using fractional amplitude of low-frequency fluctuation (fALFF) and regional homogeneity (ReHo). We analyzed fALFF and ReHo between MADs (n = 70) and healthy controls (HCs) (n = 84) and performed regression analysis using MA use variables. Compared to HCs, abstinent MADs showed increased fALFF and ReHo values in the bilateral striatum, decreased fALFF in the left inferior frontal gyrus, and decreased ReHo in the bilateral anterior cingulate cortex, sensorimotor cortex, and left precuneus. We also observed the fALFF values of bilateral striatum were positively correlated with the age of first MA use, and negatively correlated with the duration of MA use. The fALFF value of right striatum was also positively correlated with the duration of abstinence. The alterations of spontaneous cerebral activity in abstinent MADs may help us probe into the neurological pathophysiology underlying MA-related dysfunction and recovery. Since MADs with higher fALFF in the right striatum had shorter MA use and longer abstinence, the increased fALFF in the right striatum might implicate early recovery during abstinence.
Subject(s)
Methamphetamine/adverse effects , Substance Withdrawal Syndrome/diagnostic imaging , Adult , Brain Mapping , Case-Control Studies , Female , Humans , MaleABSTRACT
As a critical component of cortico-striato-thalamo-cortical loop in addiction, our understanding of the thalamus in impaired cognition of heroin users (HU) has been limited. Due to the complex thalamic connection with cortical and subcortical regions, thalamus was divided into prefrontal (PFC), occipital (OC), premotor, primary motor, sensory, temporal, and posterior parietal association subregions according to white matter tractography. We adopted seven subregions of bilateral thalamus as regions of interest to systematically study the implications of distinct thalamic nuclei in acute abstinent HU. The volume and resting-state functional connectivity (RSFC) differences of the thalamus were investigated between age-, gender-, and alcohol-matched 37 HU and 33 healthy controls (HCs). Trail making test-A (TMT-A) was adopted to assess cognitive function deficits, which were then correlated with neuroimaging findings. Although no significant different volumes were found, HU group showed decreased RSFC between left PFC_thalamus and middle temporal gyrus as well as between left OC_thalamus and inferior frontal gyrus and supplementary motor area relative to HCs. Meanwhile, the higher TMT-A scores in HU were negatively correlated with PFC_thalamic RSFC with inferior temporal gyrus, fusiform, and precuneus. Craving scores were negatively correlated with OC_thalamic RSFC with accumbens, hippocampus, and insula. Opiate Withdrawal Scale scores were negatively correlated with left PFC/OC_thalamic RSFC with orbitofrontal cortex and medial PFC. We indicated two thalamus subregions separately involvement in cognitive control and craving to reveal the implications of thalamic subnucleus in pathology of acute abstinent HU.
Subject(s)
Cerebral Cortex/physiopathology , Connectome , Heroin Dependence/physiopathology , Nerve Net/physiopathology , Substance Withdrawal Syndrome/physiopathology , Thalamus/physiopathology , Acute Disease , Adult , Cerebral Cortex/diagnostic imaging , Female , Heroin Dependence/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Nerve Net/diagnostic imaging , Substance Withdrawal Syndrome/diagnostic imaging , Thalamus/diagnostic imagingABSTRACT
Many seizure-free patients who consider withdrawing from antiepileptic drugs (AEDs) hope to discontinue treatment to avoid adverse effects. However, withdrawal has certain risks that are difficult to predict. In this study, we performed a literature review, summarized the causes of significant variability in the risk of postwithdrawal recurrent seizures, and reviewed study data on the age at onset, cause, types of seizures, epilepsy syndrome, magnetic resonance imaging (MRI) abnormalities, epilepsy surgery, and withdrawal outcomes of patients with epilepsy. Many factors are associated with recurrent seizures after AED withdrawal. For patients who are seizure-free after treatment, the role of an electroencephalogram (EEG) alone in ensuring safe withdrawal is limited. A series of prediction models for the postwithdrawal recurrence risk have incorporated various potentially important factors in a comprehensive analysis. We focused on the populations of studies investigating five risk prediction models and analyzed the predictive variables and recommended applications of each model, aiming to provide a reference for personalized withdrawal for patients with epilepsy in clinical practice.
Subject(s)
Anticonvulsants/therapeutic use , Epilepsy/diagnostic imaging , Epilepsy/drug therapy , Substance Withdrawal Syndrome/diagnostic imaging , Electroencephalography/trends , Epilepsy/physiopathology , Humans , Magnetic Resonance Imaging/trends , Predictive Value of Tests , Prospective Studies , Recurrence , Retrospective Studies , Risk Factors , Seizures/diagnostic imaging , Seizures/drug therapy , Seizures/physiopathology , Substance Withdrawal Syndrome/physiopathologyABSTRACT
While the centrality of withdrawal in the diagnosis of addiction has been decreasing with each successive edition of the Diagnostic and Statistical Manual of Mental Disorders, psychometric and neurobiological evidence provides withdrawal a central role in the development and maintenance of addiction. The current study offers insight into these conflicting positions by using secondary analyses to assess how a history of DSM-assessed withdrawal influences the magnitude of bias in neural reactivity to drug- and/or food-related reward cues. To this end, we separated an existing sample of cocaine-dependent participants (Denomme et al., 2018) into those with (WD) and without (N-WD) a history of withdrawal, and compared food- and drug-cue reactivity between these groups, and to a non-dependent control group (ND). Analyses indicated that biases in neural reactivity towards drug- versus food-related cues only occurred among the WD participants (within: left dorsomedial prefrontal cortex, left anterior cingulate cortex, left orbitofrontal cortex, left caudate nucleus, and right ventrolateral prefrontal cortex). Thus, withdrawal status may be an important factor to consider when interpreting dependence-related biases in neural reactivity following reward-related cues. Interestingly, while N-WD participants did not show these broad biases in neural reactivity, the magnitude of their bias correlated positively with years of lifetime substance use history, particularly when psychopathic traits were low. It may be that for individuals who's addiction has not yet reached a compulsive state (see Wise and Koob, 2014), the magnitude of their drug > food bias could serve as a valuable biomarker of addiction severity.
Subject(s)
Brain/diagnostic imaging , Cocaine-Related Disorders/diagnostic imaging , Cocaine/adverse effects , Cues , Food , Substance Withdrawal Syndrome/diagnostic imaging , Adult , Behavior, Addictive/diagnostic imaging , Behavior, Addictive/psychology , Cocaine-Related Disorders/psychology , Conditioning, Psychological/physiology , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Reward , Substance Withdrawal Syndrome/psychology , Young AdultABSTRACT
This study aimed to examine habenular resting state functional connectivity (RSFC) abnormalities in tobacco-smoking veterans. The authors explored RSFC in sated smokers (n = 3D 18), overnight deprived smokers (n = 3D 13), and nonsmoker controls (n = 3D 26). Seed-to-voxel analysis was used to explore RSFC in the habenula. Compared to sated smokers, deprived smokers demonstrated higher RSFC between the right habenula and two clusters of voxels: one in the right fusiform gyrus, and one in the left lingual gyrus. To study nicotine withdrawal, the authors used the Shiffman-Jarvik Withdrawal Questionnaire (SJWQ) score as a regressor and found higher RSFC between the right habenula and the left frontal pole in deprived compared to sated smokers. Right habenula RSFC distinguished between sated and deprived smokers and differentiated between sated and deprived smokers when using SJWQ as a regressor, suggesting a habenular role in tobacco withdrawal.
Subject(s)
Cerebral Cortex/physiopathology , Connectome , Habenula/physiopathology , Smoking/physiopathology , Substance Withdrawal Syndrome/physiopathology , Tobacco Use Disorder/physiopathology , Adult , Cerebral Cortex/diagnostic imaging , Connectome/methods , Female , Habenula/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Pilot Projects , Substance Withdrawal Syndrome/diagnostic imaging , Tobacco Use Disorder/diagnostic imaging , VeteransSubject(s)
Caffeine/adverse effects , Central Nervous System Stimulants/adverse effects , Cerebral Hemorrhage/etiology , Headache/etiology , Subarachnoid Hemorrhage/etiology , Substance Withdrawal Syndrome/etiology , Vasospasm, Intracranial/etiology , Cerebral Angiography , Cerebral Hemorrhage/diagnostic imaging , Computed Tomography Angiography , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Subarachnoid Hemorrhage/diagnostic imaging , Substance Withdrawal Syndrome/diagnostic imaging , Substance Withdrawal Syndrome/physiopathology , Tomography, X-Ray Computed , Vasospasm, Intracranial/diagnostic imaging , Vasospasm, Intracranial/physiopathologyABSTRACT
Cognitive dysfunction affects 40-80% of patients with multiple sclerosis. Smoking cannabis may add to these deficits. It is unclear whether coming off cannabis results in cognitive improvement. To address this question, 40 patients with multiple sclerosis who started using cannabis after the onset of multiple sclerosis and who used it for at least 4 days a week over many years were divided by odd-even number selection into two groups: cannabis continuation and cannabis withdrawal. Assessments took place at baseline and after 28 days and included serial versions of the Brief Repeatable Neuropsychological Battery for multiple sclerosis containing tests of verbal and visual memory, processing speed and executive function; structural and functional MRI, the latter entailing a compatible version of the Symbol Digit Modalities Test; urine for cannabinoid metabolites to detect compliance with abstinence. Only those participants deemed globally impaired at baseline (failure on at least two cognitive domains) were enrolled. The results revealed that the two groups were well matched demographically and neurologically. One subject was removed from the withdrawal group because of failed abstinence. Urine analysis revealed the cannabinoid consumed was predominantly tetrahydrocannabinol (THC). There were no baseline between group cognitive differences, but by Day 28 the withdrawal group performed significantly better on every cognitive index (P < 0.0001 for all). Significant within group differences were present for every test over time, but only in the abstinent group (P < 0.0001 for all tests). There were no between group baseline or Day 28 differences in structural MRI indices (global atrophy, total T1 and T2 lesion volume). At index assessment the two groups had a similar performance on the functional MRI-compatible Symbol Digit Modalities Test and there were no group differences in brain activation. However, by Day 28, the withdrawal group completed more trials correctly (P < 0.012) and had a faster reaction time (P < 0.002), associated with significantly increased activation in brain regions known to be associated with performance of the test (bilateral inferior frontal gyri, caudate and declive/cerebellum, P < 0.001 for all regions). These results reveal that patients with multiple sclerosis who are frequent, long-term cannabis users can show significant improvements in memory, processing speed and executive function after 28 days of drug abstinence. The absence of similar improvements in a matched multiple sclerosis group that remained on cannabis shows that beneficial cognitive change after stopping cannabis is not solely attributable to the effects of practice.
Subject(s)
Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/psychology , Magnetic Resonance Imaging/trends , Medical Marijuana/adverse effects , Multiple Sclerosis/diagnostic imaging , Multiple Sclerosis/psychology , Adult , Cognition/drug effects , Cognition/physiology , Cognitive Dysfunction/chemically induced , Executive Function/drug effects , Executive Function/physiology , Female , Follow-Up Studies , Humans , Male , Medical Marijuana/therapeutic use , Mental Status and Dementia Tests , Middle Aged , Multiple Sclerosis/drug therapy , Substance Withdrawal Syndrome/diagnostic imaging , Substance Withdrawal Syndrome/psychology , Withholding Treatment/trendsSubject(s)
Myocardial Perfusion Imaging , Omeprazole/administration & dosage , Stomach/drug effects , Substance Withdrawal Syndrome/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Female , Heart Ventricles/diagnostic imaging , Heart Ventricles/drug effects , Humans , Middle Aged , Proton Pump Inhibitors/administration & dosage , Technetium Tc 99m SestamibiABSTRACT
Insula dysfunction contributes to nicotine use disorders. Yet, much remains unknown about how insular functions promote nicotine use. We review current models of brain networks in smoking and propose an extension to those models that emphasizes the role of the insula in craving. During acute withdrawal, the insula provides the sensation of craving to the cerebrum and is thought to negotiate craving sensations with cognitive control to guide behavior - either to smoke or abstain. Recent studies have shown that insula processing is saturable, such that different insular functions compete for limited resources. We propose that this saturability explains how craving during withdrawal can overload insular processing to the exclusion of other functions, such as saliency and network homeostasis. A novel signal flow model illustrates how limited insular capacity leads to breakdown of normal function. Finally, we discuss suitability of insula as a neuromodulation target to promote cessation. Given the limited efficacy of standard-of-care treatments for nicotine use disorder, insular neuromodulation offers an innovative, potentially therapeutic target for improving smoking cessation.
Subject(s)
Cerebral Cortex/physiopathology , Functional Neuroimaging , Nerve Net/physiopathology , Substance Withdrawal Syndrome/physiopathology , Tobacco Use Disorder/physiopathology , Transcranial Magnetic Stimulation , Animals , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/metabolism , Humans , Nerve Net/diagnostic imaging , Nerve Net/metabolism , Substance Withdrawal Syndrome/diagnostic imaging , Substance Withdrawal Syndrome/metabolism , Tobacco Use Disorder/diagnostic imaging , Tobacco Use Disorder/metabolism , Tobacco Use Disorder/therapyABSTRACT
OBJECTIVE: Focal edema of the splenium of the corpus callosum (FESCC) is infrequently seen in patients with epilepsy who are undergoing video-electroencephalography (EEG) monitoring. It is diagnosed by qualitative visual inspection of the magnetic resonance imaging (MRI) and is usually assumed to be a dichotomous phenomenon. Rapid reduction of anticonvulsants has been proposed as a cause. In this study we investigate the relationship between dose reduction of anticonvulsants and the occurrence of FESCC, based on absolute drug doses. METHODS: We examined in detail the anticonvulsive therapy of all patients during video-EEG monitoring between 2014 and 2018. We compared patients with a radiologically diagnosed FESCC to controls in a 1:2 case-control analysis matched by age, epilepsy syndrome, and adjacent time of admission. In a separate correlation analysis, we examined quantitative effects of reduction of antiseizure drugs on diffusion restriction in the corpus callosum. RESULTS: Of 326 patients who had an MRI following video-EEG monitoring, 12 (3.7%) had FESCC. Antiseizure drugs were reduced to a significantly greater extent in FESCC patients than in the 24 controls (P < 0.001). Sodium channel-blocking antiseizure drugs were reduced (P < 0.001) and reintroduced (P < 0.001) significantly faster in FESCC patients, and the duration of anticonvulsant discontinuation was longer in FESCC patients (P < 0.001). The separate correlation analysis in 325 patients shows a weak correlation between diffusion restriction in the splenium and the reduction rate of sodium channel-blocking anticonvulsants (r = -0.15, P = 0.03) as well as the duration of their discontinuation (r = -0.16, P = 0.01). No such effects were found for anticonvulsants with other modes of action. SIGNIFICANCE: Our findings substantiate that FESCC is associated with high rates of dose reduction of anticonvulsants, specifically those acting on sodium channels. Our results cautiously suggest that reducing sodium-channel blockers has a small effect on diffusivity in the splenium below the visual threshold.
Subject(s)
Anticonvulsants/adverse effects , Brain Edema/chemically induced , Corpus Callosum , Sodium Channel Blockers/adverse effects , Substance Withdrawal Syndrome/etiology , Adolescent , Adult , Aged , Anticonvulsants/administration & dosage , Anticonvulsants/therapeutic use , Brain Edema/diagnostic imaging , Case-Control Studies , Child , Child, Preschool , Corpus Callosum/diagnostic imaging , Corpus Callosum/pathology , Electroencephalography , Epilepsy/drug therapy , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Sodium Channel Blockers/administration & dosage , Sodium Channel Blockers/therapeutic use , Substance Withdrawal Syndrome/diagnostic imaging , Young AdultABSTRACT
Although 60% of the US population have tried smoking cigarettes, only 16% smoke regularly. Identifying this susceptible subset of the population before the onset of nicotine dependence may encourage targeted early interventions to prevent regular smoking and/or minimize severity. While prospective neuroimaging in human populations can be challenging, preclinical neuroimaging models before chronic nicotine administration can help to develop translational biomarkers of disease risk. Chronic, intermittent nicotine (0, 1.2, or 4.8 mg/kg/d; N = 10-11/group) was administered to male Sprague Dawley rats for 14 d; dependence severity was quantified using precipitated withdrawal behaviors collected before, during, and following forced nicotine abstinence. Resting-state fMRI functional connectivity (FC) before drug administration was subjected to a graph theory analytical framework to form a predictive model of subsequent individual differences in nicotine dependence. Whole-brain modularity analysis identified five modules in the rat brain. A metric of intermodule connectivity, participation coefficient, of an identified insular-frontal cortical module predicted subsequent dependence severity, independent of nicotine dose. To better spatially isolate this effect, this module was subjected to a secondary exploratory modularity analysis, which segregated it into three submodules (frontal-motor, insular, and sensory). Higher FC among these three submodules and three of the five originally identified modules (striatal, frontal-executive, and sensory association) also predicted dependence severity. These data suggest that predispositional, intrinsic differences in circuit strength between insular-frontal-based brain networks before drug exposure may identify those at highest risk for the development of nicotine dependence.SIGNIFICANCE STATEMENT Developing biomarkers of individuals at high risk for addiction before the onset of this brain-based disease is essential for prevention, early intervention, and/or subsequent treatment decisions. Using a rodent model of nicotine dependence and a novel data-driven, network-based analysis of resting-state fMRI data collected before drug exposure, functional connections centered on an intrinsic insular-frontal module predicted the severity of nicotine dependence after drug exposure. The predictive capacity of baseline network measures was specific to inter-regional but not within-region connectivity. While insular and frontal regions have consistently been implicated in nicotine dependence, this is the first study to reveal that innate, individual differences in their circuit strength have the predictive capacity to identify those at greatest risk for and resilience to drug dependence.
Subject(s)
Cerebral Cortex/diagnostic imaging , Frontal Lobe/diagnostic imaging , Nerve Net/diagnostic imaging , Nicotine/administration & dosage , Substance Withdrawal Syndrome/diagnostic imaging , Tobacco Use Disorder/diagnostic imaging , Animals , Cerebral Cortex/drug effects , Frontal Lobe/drug effects , Functional Neuroimaging , Genetic Testing , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Nerve Net/drug effects , Nicotine/adverse effects , Rats , Rats, Sprague-Dawley , Severity of Illness IndexABSTRACT
Opioid use disorder (OUD) is associated with the emergence of persistent negative emotional states during drug abstinence that drive compulsive drug taking and seeking. Functional magnetic resonance imaging (fMRI) in rats identified neurocircuits that were activated by stimuli that were previously paired with heroin withdrawal. The activation of amygdala and hypothalamic circuits was related to the degree of heroin dependence, supporting the significance of conditioned negative affect in sustaining compulsive-like heroin seeking and taking and providing neurobiological insights into the drivers of the current opioid crisis.